These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10665814)

  • 21. Antihypertensive effects of the putative T-type calcium channel antagonist mibefradil are mediated by the L-type calcium channel Cav1.2.
    Moosmang S; Haider N; Brüderl B; Welling A; Hofmann F
    Circ Res; 2006 Jan; 98(1):105-10. PubMed ID: 16306443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nickel block of a family of neuronal calcium channels: subtype- and subunit-dependent action at multiple sites.
    Zamponi GW; Bourinet E; Snutch TP
    J Membr Biol; 1996 May; 151(1):77-90. PubMed ID: 8661496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Towards selective antagonists of T-type calcium channels: design, characterization and potential applications of NNC 55-0396.
    Li M; Hansen JB; Huang L; Keyser BM; Taylor JT
    Cardiovasc Drug Rev; 2005; 23(2):173-96. PubMed ID: 16007233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential blocking action of dihydropyridine Ca2+ antagonists on a T-type Ca2+ channel (alpha1G) expressed in Xenopus oocytes.
    Furukawa T; Nukada T; Miura R; Ooga K; Honda M; Watanabe S; Koganesawa S; Isshiki T
    J Cardiovasc Pharmacol; 2005 Mar; 45(3):241-6. PubMed ID: 15725949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mibefradil metabolite is a potent intracellular blocker of L-type Ca(2+) currents in pancreatic beta-cells.
    Wu S; Zhang M; Vest PA; Bhattacharjee A; Liu L; Li M
    J Pharmacol Exp Ther; 2000 Mar; 292(3):939-43. PubMed ID: 10688607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Permeant ion binding affinity in subconductance states of an L-type Ca2+ channel expressed in Xenopus laevis oocytes.
    Cloues RK; Sather WA
    J Physiol; 2000 Apr; 524 Pt 1(Pt 1):19-36. PubMed ID: 10747181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Voltage-dependent calcium channels.
    Lacinová L
    Gen Physiol Biophys; 2005 Jun; 24 Suppl 1():1-78. PubMed ID: 16096350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Facilitation of Ca2+-activated K+ channels (IKCa1) by mibefradil in B lymphocytes.
    Yoo HY; Zheng H; Nam JH; Nguyen YH; Kang TM; Earm YE; Kim SJ
    Pflugers Arch; 2008 Jun; 456(3):549-60. PubMed ID: 18188587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mibefradil potently blocks ATP-activated K(+) channels in adrenal cells.
    Gomora JC; Enyeart JA; Enyeart JJ
    Mol Pharmacol; 1999 Dec; 56(6):1192-7. PubMed ID: 10570046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of recombinant Ca2+ channels by benzothiazepines and phenylalkylamines: class-specific pharmacology and underlying molecular determinants.
    Cai D; Mulle JG; Yue DT
    Mol Pharmacol; 1997 May; 51(5):872-81. PubMed ID: 9145926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of mibefradil on voltage-dependent gating and kinetics of T-type Ca(2+) channels in cortisol-secreting cells.
    Gomora JC; Xu L; Enyeart JA; Enyeart JJ
    J Pharmacol Exp Ther; 2000 Jan; 292(1):96-103. PubMed ID: 10604935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of mibefradil block of the human heart delayed rectifier hKv1.5.
    Perchenet L; Clément-Chomienne O
    J Pharmacol Exp Ther; 2000 Nov; 295(2):771-8. PubMed ID: 11046117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrasting biophysical and pharmacological properties of T-type and R-type calcium channels.
    Randall AD; Tsien RW
    Neuropharmacology; 1997 Jul; 36(7):879-93. PubMed ID: 9257934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ca2+ flux through voltage-gated channels with flow cessation in pulmonary microvascular endothelial cells.
    Wei Z; Manevich Y; Al-Mehdi AB; Chatterjee S; Fisher AB
    Microcirculation; 2004 Sep; 11(6):517-26. PubMed ID: 15371132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of L-type Ca2+ channel current in Xenopus oocytes by amiodarone.
    Ding S; Chen F; Klitzner TS; Wetzel GT
    J Investig Med; 2001 Jul; 49(4):346-52. PubMed ID: 11478411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of maximal open probability is a separable function of Ca(v)beta subunit in L-type Ca2+ channel, dependent on NH2 terminus of alpha1C (Ca(v)1.2alpha).
    Kanevsky N; Dascal N
    J Gen Physiol; 2006 Jul; 128(1):15-36. PubMed ID: 16801381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Motif III S5 of L-type calcium channels is involved in the dihydropyridine binding site. A combined radioligand binding and electrophysiological study.
    He M; Bodi I; Mikala G; Schwartz A
    J Biol Chem; 1997 Jan; 272(5):2629-33. PubMed ID: 9006896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential role of the alpha1C subunit tails in regulation of the Cav1.2 channel by membrane potential, beta subunits, and Ca2+ ions.
    Kobrinsky E; Tiwari S; Maltsev VA; Harry JB; Lakatta E; Abernethy DR; Soldatov NM
    J Biol Chem; 2005 Apr; 280(13):12474-85. PubMed ID: 15671035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition by mibefradil, a novel calcium channel antagonist, of Ca(2+)- and volume-activated Cl- channels in macrovascular endothelial cells.
    Nilius B; Prenen J; Kamouchi M; Viana F; Voets T; Droogmans G
    Br J Pharmacol; 1997 Jun; 121(3):547-55. PubMed ID: 9179399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The block of the expressed L-type calcium channel is modulated by the beta 3 subunit.
    Lacinová L; Ludwig A; Bosse E; Flockerzi V; Hofmann F
    FEBS Lett; 1995 Oct; 373(2):103-7. PubMed ID: 7589444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.